Latest Trends in GLP-1 Weight Loss Medications for 2025
Understanding the Evolution of GLP-1 Receptor Agonists in Weight Management As we approach 2025, the landscape of weight loss pharmacotherapy is undergoing a significant transformation driven by the latest advancements in glucagon-like peptide-1 (GLP-1) receptor agonists. These medications, initially developed for type 2 diabetes management, are now at the forefront of obesity treatment due to … Read more